← Weight Loss & Metabolic

Semaglutide Microdose

The same semaglutide and B12 vial as Semaglutide/B12, taken at a much smaller dose (10 units twice weekly) for people who want to ease in.

Dr. Jonathan Snipes, MDMedically reviewed by Dr. Jonathan Snipes, MD. Last reviewed May 6, 2026.
Semaglutide Microdose dispensed by a licensed U.S. 503A compounding pharmacy

Verify us before you order

Which semaglutide is right for me?

All 3 have the same active ingredient. They differ in what it is compounded with and how much you take. Your provider reviews the choice before anything is prescribed.

Gentle MicrodoseAppetite SupportFewer Side EffectsCompounded with B12

What It Is

This is compounded semaglutide, not pure semaglutide. A licensed U.S. 503A compounding pharmacy compounds it as semaglutide co-formulated with cyanocobalamin (vitamin B12) in the same vial, so every injection contains both. Semaglutide is a GLP-1 receptor agonist, the same active ingredient as Ozempic® and Wegovy®. It is the identical vial we prescribe as Semaglutide/B12, just drawn at a much smaller dose, so the vial lasts longer than standard dosing.

How It Works

It mimics the GLP-1 hormone your body makes after eating, telling your brain you're full and slowing digestion. At microdose levels the effect is milder and slower, which suits people who want to ease in or who are side-effect sensitive. The B12 is a carrier that supports energy levels during weight loss. It does not change how semaglutide works and does not add to weight loss on its own.

Who It's For

Adults who want a gentle entry to GLP-1 therapy, are sensitive to side effects, or are microdosing for appetite and metabolic support alongside diet and exercise. Not for patients with a known B12 sensitivity, who should ask their provider about the B6/glycine formulation instead.

Who Should Avoid It

Not for those with personal/family history of thyroid cancer (MTC), MEN2 syndrome, active pancreatitis, or severe gastroparesis. Not suitable during pregnancy. Also avoid if you have reacted to cyanocobalamin (B12), since it is compounded into this vial.

Ready to add Semaglutide Microdose?

A licensed provider reviews every order.


Semaglutide Microdose Side Effects

Compounded semaglutide is not FDA approved and has no trials of its own. The numbers below come from the FDA label for Wegovy®, the brand-name semaglutide taken once a week, in adults treated for weight loss. Our dosing is twice a week, so use them as a guide.

The microdose is below the lowest dose in this table, and the Wegovy® label does not report side effects at doses that low.

Most common side effects

Percent of people in each group, Wegovy® once weekly versus placebo.
Side effectPlacebo2.4 mg
Nausea16%44%
Diarrhea16%30%
Vomiting6%24%
Constipation11%24%
Stomach pain (abdominal pain)10%20%
Headache10%14%
Tiredness (fatigue)5%11%
Indigestion (dyspepsia)3%9%
Dizziness4%8%
Bloating (abdominal distension)5%7%
Burping (eructation)<1%7%
Gas (flatulence)4%6%
Stomach flu (gastroenteritis)4%6%
Acid reflux (GERD)3%5%
Hair loss1%3%

Serious risks on the label

  • Thyroid C-cell tumors: semaglutide caused them in rodents, and it is unknown whether it does in people. Do not use it if you or a family member has had medullary thyroid cancer, or if you have MEN 2 (boxed warning).
  • Severe stomach and bowel side effects.
  • Kidney injury from dehydration after nausea, vomiting or diarrhea.
  • Gallbladder problems.
  • Pancreatitis (an inflamed pancreas).
  • Serious allergic reactions.
  • Low blood sugar. The risk is higher with insulin or a medicine that makes the body release more insulin, such as a sulfonylurea.
  • Worsening diabetic eye disease in people with type 2 diabetes.
  • Food or liquid getting into the lungs during anesthesia or deep sedation. Tell the care team about it before any procedure.
  • A faster heart rate.

Tell your provider about any of these in your health screening. Your provider reviews your history before anything is prescribed.

Source: Wegovy (semaglutide) prescribing information, Revised 06/2026, Table 3, adults with obesity or overweight on Wegovy injection; section 5 and the boxed warning.

Ready to add Semaglutide Microdose?

A licensed provider reviews every order.


Protocol & Pricing

Pharmacy Price

$9.60/1.2mg

You pay pharmacy price. No markup.

Starting Dose

10 units twice weekly (0.06mg per injection, 0.12mg per week)

Form

Injectable vial (2mL, 0.6mg/mL, 1.2mg total. Compounded semaglutide + B12, not pure semaglutide)


Dosing Protocol

10 units subcutaneous injection twice weekly, 3 to 4 days apart. 10 units = 0.1mL × 0.6mg/mL = 0.06mg per injection (0.12mg per week). Your provider may step the dose up every 4 weeks as tolerated. Hold or step back dose if nausea. Hydration & protein mitigate side effects.

Beyond Use Date

90 Days from compounding (USP <797>)

A licensed U.S. 503A compounding pharmacy assigns this date and prints it on your vial label. Always follow the label.

Ready to add Semaglutide Microdose?

A licensed provider reviews every order.


Why this dose, and what the evidence shows

From our medical director's protocol for Semaglutide Microdose. Where the evidence is thin, it says so.

Why this dose

Semaglutide has a half-life of about one week.

This protocol divides the weekly amount into two smaller injections. Splitting the weekly amount changes the concentration pattern while preserving the same total weekly dose.

Some clinicians use divided dosing for patients who prefer smaller individual injections or report gastrointestinal symptoms with larger single doses.

Clinical trials have not established divided twice-weekly dosing as superior to standard once-weekly administration.


What the evidence shows

Semaglutide has extensive human clinical evidence for weight management and metabolic disease at established therapeutic doses.

The standard labeled starting dose is 0.25 mg once weekly, followed by gradual dose increases.

Published clinical evidence below 0.25 mg per week is limited.

A microdose protocol therefore aims to identify the lowest amount associated with an individual response rather than reproduce the weight-loss results seen with standard therapeutic dosing.

Patients should expect response to vary, particularly at doses below those used in major clinical trials.

Each order also carries the $39 prescriber review. Pharmacy prices are the pharmacy's own; we add nothing to them.

Ready to add Semaglutide Microdose?

A licensed provider reviews every order.


Stacking Guide

Do Not Combine With

Semaglutide/B12Semaglutide/B6 + GlycineTirzepatide/B12Tirzepatide/B6 + GlycineTirzepatide Microdose

Ready to add Semaglutide Microdose?

A licensed provider reviews every order.


Independently tested

Semaglutide Microdose certificate of analysis

All 4 Semaglutide Microdose samples tested for sterility and endotoxin passed both. Latest sample received by the lab Oct 12, 2026.

Every Semaglutide Microdose batch dispensed by a licensed U.S. 503A compounding pharmacy is independently tested by Eagle Analytical Services (FDA-registered, A2LA ISO 17025 accredited). Sterility testing checks that nothing grows in the sample; the USP <85> endotoxin test checks for bacterial toxins that can cause fever. Below is the lab's own report for each of the 4 most recent lots.

Lot LG342011270, received Oct 12, 2026

Sterility
PassScanRDI Sterility Test. Started Oct 12, 2026, completed Oct 13, 2026. Method suitability ETX-260309-0642
Bacterial endotoxin
PassUSP <85>. Measured <2 EU/mL, limit 700 EU/mL. Started Oct 14, 2026, completed Oct 14, 2026
Sample, as printed
SEMAGLUTIDE/ B12 0.6 MG/ 500 MCG/ML (2 ML) Injection
Lot #
LG342011270
Storage
Refrigerated
Received by lab
Oct 12, 2026
Laboratory
Eagle Analytical Services Inc., Houston, TX
Submission #
ETX-261012-0709
Signed
Alison Eng, Quality Control Manager
Scan of Eagle Analytical report ETX-261012-0709 for lot LG342011270. Opens the original PDF.
Eagle Analytical report ETX-261012-0709. Open the original PDF (opens in a new tab)

Eagle Analytical Services is an independent FDA-registered laboratory, A2LA accredited to ISO 17025, based in Houston, Texas. They have no commercial relationship with Rx Peps Direct. Rx Peps Direct prescribes; the pharmacy compounds and dispenses; Eagle tests every batch. Three separate companies. Results apply only to the tested sample as received. Browse our full quality program on the quality page.

Ready to add Semaglutide Microdose?

A licensed provider reviews every order.


How to get Semaglutide Microdose prescribed online

Semaglutide Microdose is available by prescription after an online medical review and dispensed for human use by a licensed 503A pharmacy. That is what separates it from research-use-only vials sold without a prescription. There is no membership, just a medical review fee per order, and automatic refills are optional.

  1. 1

    Complete a $39 medical review. Answer a short intake about your health history and your goals for Semaglutide Microdose. The $39 fee is the only charge Rx Peps Direct collects, paid once, not a recurring subscription.

  2. 2

    A licensed provider reviews it. A US-licensed clinician reviews your intake and, if Semaglutide Microdose is appropriate for you, writes a patient-specific prescription. The starting dose is typically 10 units twice weekly (0.06mg per injection, 0.12mg per week).

  3. 3

    The pharmacy compounds and ships it. A licensed 503A compounding pharmacy in Texas compounds Semaglutide Microdose and ships it pre-reconstituted by FedEx overnight in a reusable cooled case. Your fill is Injectable vial (2mL, 0.6mg/mL, 1.2mg total. Compounded semaglutide + B12, not pure semaglutide), and you pay the pharmacy $9.60/1.2mg at wholesale, with no clinic markup, plus a $15 flat FedEx overnight shipping fee charged by the pharmacy.

Rx Peps Direct prescribes Semaglutide Microdose in the 28 states plus Washington, DC where its medical team is licensed. Start your $39 medical review or browse all peptides for weight loss. Comparing services first? See how Rx Peps Direct stacks up against seven other providers in our best telehealth for compounded peptides comparison.

Ready to add Semaglutide Microdose?

A licensed provider reviews every order.


Common questions about Semaglutide Microdose

What is in the Semaglutide Microdose vial?
Each vial contains compounded semaglutide co-formulated with cyanocobalamin (vitamin B12), suspended together in the same solution. It is not pure semaglutide and it is not a research-use vial. The pharmacy compounds it under a 503A patient-specific prescription, and the label lists both ingredients. The vial is 2 mL at 0.6 mg/mL (1.2 mg total) for $9.60, plus a flat $39 medical review. Every batch is tested by Eagle Analytical Services for sterility and bacterial endotoxin (USP <85>); the Certificate of Analysis is published on this page.
Is this pure semaglutide?
No. This is a compounded medication, which means the pharmacy prepares semaglutide together with vitamin B12 in one vial rather than dispensing the semaglutide molecule on its own. Anyone selling a vial labeled pure semaglutide for human use outside a compounding pharmacy is selling a research-use product without a prescription. The semaglutide in this vial is the same active ingredient as Ozempic and Wegovy, and the B12 does not change how it binds the GLP-1 receptor.
How is this different from the standard Semaglutide/B12 vial?
It is the same vial. Same pharmacy, same 0.6 mg/mL concentration, same 1.2 mg total, same $9.60 price. The only difference is the dose your provider writes: the microdose protocol starts at 10 units (0.06 mg) twice weekly, 0.12 mg per week, where the standard protocol starts at 25 units (0.15 mg) twice weekly, 0.3 mg per week. Because you draw less per injection, a single vial lasts considerably longer.
Why is vitamin B12 in a weight loss injection?
Cyanocobalamin is a stable form of vitamin B12 that acts as a soluble carrier in the formulation and supports red blood cell production and energy metabolism during caloric restriction. The 0.5 mg/mL inclusion is below any clinical toxicity threshold and has no effect on semaglutide's GLP-1 receptor binding, so it does not add to your weight loss results. The B12 carrier is a formulation choice by a licensed U.S. 503A compounding pharmacy, not by Rx Peps Direct.
What if I cannot tolerate B12?
Tell your provider during the intake. Patients with a documented B12 sensitivity, an MTHFR methylation variant, or a history of reacting to cyanocobalamin should ask about the Semaglutide/B6 + Glycine formulation instead, which uses glycine and vitamin B6 as the carrier and contains no B12. It is the same semaglutide active ingredient. Do not order this microdose vial if you have reacted to B12 before.
What is the starting dose for the semaglutide microdose protocol?
10 units on a U-100 insulin syringe, injected subcutaneously twice weekly, 3 to 4 days apart. On the 0.6 mg/mL vial, 10 units equals 0.1 mL, which is 0.06 mg per injection or 0.12 mg per week. For comparison, the standard Rx Peps Direct protocol is 0.15 mg twice weekly and branded Wegovy starts at 0.25 mg once weekly. Your provider confirms or adjusts the units at review and may step the dose up every 4 weeks as tolerated. Always verify the concentration printed on your vial before drawing.
How long does a microdose vial last?
At the 10 unit twice-weekly starting dose, a 1.2 mg vial holds 20 doses, which is 10 weeks. A step up in dose shortens that. The Beyond Use Date (BUD) is 90 days from compounding under USP <797> sterile compounding standards and is printed on every vial label. Once opened, keep the vial in the fridge and use it until it is empty or it reaches the date printed on its label, whichever comes first. Refrigerate at 36 to 46 degrees Fahrenheit and do not freeze. Discard at the BUD even if solution remains.

Ready to add Semaglutide Microdose?

A licensed provider reviews every order.